Biological molecules in the treatment of hematological disorders.
Kurzrock
R
R
Talpaz
M
M
Gutterman
U
U
D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D004921:Erythropoietin / Q000627:therapeutic use; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000627:therapeutic use*; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D007371:Interferon-gamma / Q000627:therapeutic use; D007372:Interferons / Q000627:therapeutic use*; D007377:Interleukin-3 / Q000627:therapeutic use; D007938:Leukemia / Q000628:therapy*; D007943:Leukemia, Hairy Cell / Q000628:therapy; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D009190:Myelodysplastic Syndromes / Q000628:therapy*; D011994:Recombinant Proteins; D013920:Thrombocythemia, Essential / Q000628:therapy*
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D007370:Interferon Type I; D007377:Interleukin-3; D011994:Recombinant Proteins; D004921:Erythropoietin; D016179:Granulocyte Colony-Stimulating Factor; D007371:Interferon-gamma; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D007372:Interferons